Hardy T - Search Results

1

Ultrarapid Lispro Demonstrates Similar Time in Target Range to Lispro with a Hybrid Closed-Loop System.

Bode B, Carlson A, Liu R, Hardy T, Bergenstal R, Boyd J, Morrett S, Ignaut D. Bode B, et al. Among authors: hardy t. Diabetes Technol Ther. 2021 Dec;23(12):828-836. doi: 10.1089/dia.2021.0184. Epub 2021 Oct 26. Diabetes Technol Ther. 2021. PMID: 34270335 Clinical Trial.

2

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.

Kazda CM, Ding Y, Kelly RP, Garhyan P, Shi C, Lim CN, Fu H, Watson DE, Lewin AJ, Landschulz WH, Deeg MA, Moller DE, Hardy TA. Kazda CM, et al. Diabetes Care. 2016 Jul;39(7):1241-9. doi: 10.2337/dc15-1643. Epub 2015 Dec 17. Diabetes Care. 2016. PMID: 26681715 Clinical Trial.

3

Treatment with the glucagon receptor antagonist LY2409021 increases ambulatory blood pressure in patients with type 2 diabetes.

Kazda CM, Frias J, Foga I, Cui X, Guzman CB, Garhyan P, Heilmann C, Yang JA, Hardy TA. Kazda CM, et al. Diabetes Obes Metab. 2017 Aug;19(8):1071-1077. doi: 10.1111/dom.12904. Epub 2017 Mar 27. Diabetes Obes Metab. 2017. PMID: 28191913 Clinical Trial.

4

Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes.

Guzman CB, Zhang XM, Liu R, Regev A, Shankar S, Garhyan P, Pillai SG, Kazda C, Chalasani N, Hardy TA. Guzman CB, et al. Diabetes Obes Metab. 2017 Nov;19(11):1521-1528. doi: 10.1111/dom.12958. Epub 2017 Jun 8. Diabetes Obes Metab. 2017. PMID: 28371155 Free article. Clinical Trial.

5

Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy.

Malecki MT, Cao D, Liu R, Hardy T, Bode B, Bergenstal RM, Bue-Valleskey J. Malecki MT, et al. Among authors: hardy t. Diabetes Technol Ther. 2020 Nov;22(11):853-860. doi: 10.1089/dia.2020.0129. Epub 2020 Jun 10. Diabetes Technol Ther. 2020. PMID: 32453647 Free PMC article. Clinical Trial.

6

Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study.

Bode BW, Garg SK, Norwood P, Morales C, Hardy T, Liu R, Ignaut D. Bode BW, et al. Among authors: hardy t. Diabetes Technol Ther. 2021 Jan;23(1):41-50. doi: 10.1089/dia.2020.0224. Epub 2020 Jul 30. Diabetes Technol Ther. 2021. PMID: 32640842 Clinical Trial.

7

Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2.

Warren M, Bode B, Cho JI, Liu R, Tobian J, Hardy T, Chigutsa F, Phillip M, Horowitz B, Ignaut D. Warren M, et al. Among authors: hardy t. Diabetes Obes Metab. 2021 Jul;23(7):1552-1561. doi: 10.1111/dom.14368. Epub 2021 Mar 23. Diabetes Obes Metab. 2021. PMID: 33687783 Free PMC article. Clinical Trial.

8

Simulation-Based Evaluation of Dose Titration Algorithms for U-500R Insulin by Pump in Subjects with Type 2 Diabetes.

Ma X, Waterhouse T, Ilag LL, Ly T, Juneja R, Garhyan P, Hardy T, Hood RC. Ma X, et al. Among authors: hardy t. J Diabetes Sci Technol. 2021 Sep;15(5):1195-1197. doi: 10.1177/19322968211026626. Epub 2021 Jul 1. J Diabetes Sci Technol. 2021. PMID: 34210191 Free PMC article. No abstract available.

9

Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double-blind meal test early-phase study.

Kazda C, Leohr J, Liu R, Reddy S, Dellva MA, Loh MT, Hardy T, Plum-Mörschel L. Kazda C, et al. Among authors: hardy t. Diabetes Obes Metab. 2022 Feb;24(2):196-203. doi: 10.1111/dom.14563. Epub 2021 Oct 24. Diabetes Obes Metab. 2022. PMID: 34595812 Free PMC article. Clinical Trial.

10

Ultra-rapid lispro shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early phase study.

Leohr J, Kazda C, Liu R, Reddy S, Dellva MA, Matzopoulos M, Loh MT, Hardy T, Klein O, Kapitza C. Leohr J, et al. Among authors: hardy t. Diabetes Obes Metab. 2022 Feb;24(2):187-195. doi: 10.1111/dom.14561. Epub 2021 Oct 27. Diabetes Obes Metab. 2022. PMID: 34605142 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

491 results

Search Page

Filters